In short
The Rich Roll Podcast: Episode Summary
Episode Title
The Dean of Stanford Medical School on How AI Is Shaping The Future of Health Precision
Guest
Dr. Lloyd Minor
- Position: Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University.
Overview In this episode, Rich Roll engages Dr. Lloyd Minor in a discussion about the transformative impact of Artificial Intelligence (AI) on healthcare. The conversation touches on various aspects such as diagnostics, drug discovery, medical education, ethical considerations, and the future of healthcare technologies.
---
Key Themes and Discussions
- Transformative Potential of AI in Healthcare
- AI as a Major Breakthrough: Dr. Minor emphasizes that AI represents medicine's most significant advancement since antibiotics.
- Applications of AI:
- Diagnostics: Increasing accuracy in disease detection (e.g., AI-assisted dermatology).
- Drug Discovery: Enhancing the efficiency of developing new drugs through better modeling of biological processes.
- Patient Care: Making healthcare delivery more accessible, safer, and equitable.
- Pros and Cons of AI in Healthcare
- Pros:
- Improved accuracy and efficiency in diagnostics.
- Enhanced drug discovery processes.
- Ability to analyze large datasets to identify trends and predict health issues.
- Cons:
- Potential risks include data privacy concerns and the reliability of AI systems.
- Ethical considerations regarding bias in AI algorithms and maintaining the doctor-patient relationship.
- Wearable Technologies and Precision Health
- Wearable Devices: Discussed the role of wearables in monitoring health metrics and early disease detection.
- Precision Health vs. Precision Medicine:
- Precision Medicine: Focuses on treatment after disease onset.
- Precision Health: Aims at predictive measures to prevent disease.
- Changes in Medical Education
- Evolution of Medical Training:
- An emphasis on understanding AI tools rather than memorization.
- Integration of virtual reality (VR) and augmented reality (AR) in medical education.
- Changing Curriculum: Encouraging the teaching of nutrition and lifestyle medicine.
- Ethical and Regulatory Considerations
- Raise Health Initiative: Focuses on ensuring the responsible use of AI in healthcare while addressing privacy and equity concerns.
- Regulatory Landscape: The FDA and other organizations are adapting to understand and oversee AI applications in healthcare.
- Challenges and the Future of Healthcare Delivery
- Systemic Issues: Acknowledged the complexities of the current healthcare system, emphasizing the need for transformative changes that go beyond incremental improvements.
- Future Predictions:
- Increased integration of AI in diagnostics and monitoring.
- Development of 3D-printed organs and advanced therapeutic options.
---
Key Takeaways
- Collaboration is Key: Engaging stakeholders, including the public, in discussions about AI in healthcare is crucial for transparency and trust.
- Empower Individuals: Patients should be informed and empowered to take an active role in their health management.
- Future Excitement: The convergence of various scientific fields with healthcare presents unprecedented opportunities for innovation and improved health outcomes.
---
Conclusion The episode with Dr. Lloyd Minor provides a comprehensive look into how AI is reshaping the landscape of healthcare. The discussions underscore the importance of ethical considerations, the evolving nature of medical education, and the need for a collaborative approach in implementing these transformative technologies. As we move forward, the potential for AI to enhance healthcare delivery is immense, but it must be navigated thoughtfully to safeguard public trust and health outcomes.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:00We're brought to you today by Momentus. As an athlete, as a cookbook author, a wellness advocate, and a podcaster who has hosted conversations with countless experts on diet and nutrition, I can tell you that nutrition is extremely complicated, extremely personal, all of which has made me more skeptical than I once was when it comes to supplementation products and the claims they make. That said, I truly do believe in responsible supplementation as an important part of nutritional health. Even the most diet rigorous among us has deficiencies, many of which go unnoticed until we undergo a comprehensive blood profile.
0:38All of which is why it's very important to be conscientious when it comes to selecting supplement products, which is what Momentus is all about as a company that is radically committed to quality, rigor, and purity, which they call the Momentus standard, an approach to nutrition that truly captures the essence of performance for life. Where most brands perform cursory checks, Momentus actually conducts exhaustive NSF certified testing that goes well beyond industry norms. Every batch is meticulously examined for purity, label accuracy, and potential banned substances. Their philosophy is simple.
1:13If a batch doesn't meet their exacting standards, it simply doesn't exist. For someone always seeking the most intentional approach to nutrition, Momentus represents a genuine commitment to performance for life. A reminder that nutrition is about supporting our body's potential, not just filling a gap. So if you're ready to elevate your nutrition, head to livemomentus.com slash richroll or use the code richroll at checkout for 35 % off your first subscription. That's livemomentus.com slash richroll for 35 % off your first subscription. We ought to be able to get a better picture moment to moment on the status of our health and therefore be able to act upon early signs in ways we haven't been able to do in the past.
1:59How is technology, specifically artificial intelligence, changing the landscape of medicine and health care? There will be some revolutionary changes in diagnostics, revolutions in drug discovery, better therapeutics, and that's going to improve health and well-being. Dr. Lloyd Minor is the dean of Stanford Medical School and also serves as Stanford University's vice president for medical affairs. I do think medical education is going to be significantly different a decade from now because of large language models and just the information that they bring to people's fingertips. He believes AI is medicine's biggest moment since the invention of antibiotics.
2:42There's never been a better time to be in the life sciences than today. We're training a model based on a lot more data than an individual pathologist will be able to see in their lifetime. We also discuss, of course, the ethical considerations this technology demands, as well as the many dizzying ways AI isn't just changing the healthcare game, it's actually creating a new game altogether. It's my privilege to share his insights with you today. So here we go. This is me and Dr. Lloyd Miner.
3:19Thank you for doing this, Lloyd. I appreciate it. I'm honored to be here. Really have enjoyed following your podcasts and learning from you and your guests. I appreciate that. That's very meaningful to hear. So thank you for that. I think before we get into the subject matters at hand, I'd love to kind of better understand your job. What does it mean to be the dean of Stanford Medical School? Elaborate on what that role is and what your responsibilities are. Sure. Well, fundamentally, my job is about people, and I have the privilege of working with some truly amazing people every day. People, faculty.
3:57Faculty really do everything that's part of our mission. And what is our mission? It really has three parts, patient care, research, and teaching. And those three components are synergistic. So the research we do drives advances in patient care. Students, medical students, Ph.D. students, master's degree students, clinical fellows and residents, they come to learn from our faculty and to be able to advance their skills and their knowledge and also learn the art and the science of medicine for those that are involved in clinical medicine. So my job is, broadly speaking, to work with the people that make this happen on a daily basis, to make sure that we're garnering the resources that enable the people to succeed, and also to help in setting the strategy for the overall enterprise to lead the strategic planning initiatives that are part of the enterprise.
4:57I would imagine it's a delicate balance to kind of attend to the interest, the specific interests of these various pillars, the business of the medical school, the clinical aspect of it, the patient care aspect of it, because those interests don't necessarily always align. And so it centers you in sort of a political role where you have to kind of navigate the various interests and kind of do that amidst a group of people who are diverse in their interests, aims, and goals. That's right. That's why the job is never boring, which is wonderful. You seem to have a very kind of genial disposition, though.
5:41I think you have to be. I think also one has to be very positive. There's a lot of reason to be positive. We have to look at challenges as opportunities. And I try to understand, and yes, there are situations where interests are not aligned. And that, just as you pointed out, is somewhat inherent in the nature of the enterprise. There are so many related but sometimes divergent goals and initiatives within the umbrella of an academic medical center and a school of medicine. And the job of leadership is to work as hard as we can to harmonize those. And in most cases, you can find synergies when you look hard enough and you look beyond the apparent conflicts.
6:27But there are conflicts, and there you try to approach them with an attitude of fairness. and looking for ways in which everyone succeeds, even if not everyone gets exactly what they came in desiring to have. Well, that's a keystone of negotiation, right? It is. Having everybody walk away with some kind of win, right? Precisely. Yeah. Precisely. Well, you are here because you are at the forefront of this brand new technology that we're all kind of inelegantly trying to wrap our heads and minds around. which is artificial intelligence. So explain to me how this first kind of became interesting to you and what convinced you that this is the massive breakthrough that you present it to be in terms of medicine, medical education, diagnostics, healthcare, basically everything.
7:28Yes, and Rich, I think you summarized it well. It does encompass so many things. And the use of artificial intelligence or the elements of artificial intelligence in the delivery of health care dates back quite a while. For example, today, when we go to a physician or other health care provider and we get a prescription for a medication, it would be very rare today that we actually get a handwritten prescription. prescription. That's mostly entered, and certainly in the hospital setting, always entered electronically. What moving to electronic patient records and electronic ordering systems did was to enable us to be safer in how those prescriptions are written, delivered, filled.
8:11So now an error, which can happen, a decimal point gets moved. Sometimes maybe someone prescribing a medicine doesn't know, doesn't realize that the person's on a medicine that actually has an adverse reaction to the medicine they're prescribing. Now all of that gets reconciled electronically. So that's a form of crude, rudimentary form of the application of artificial intelligence to a process, namely prescribing of medications. As our ability, as the algorithms driving AI have evolved, and as the systems for taking in vast amounts of data have grown, now we're able to apply AI in ways that we couldn't have even dreamed about five years ago.
8:58The traditional, more traditional forms of AI that usually are described with machine learning or deep neural networks. And now more recently, there have been the large language models or transformer models that I think open a whole new vista of opportunities in healthcare, fundamental life sciences discovery, and pretty much everything that underlies our business. So what are the pros? Let's get into the pros before we talk about the cons and the ethical dilemmas that are presented. What are we looking at in terms of what we can imagine with this power now at our behest? I think the pros are that AI will help healthcare delivery to be more accessible, to be safer, that AI will help discovery all the way from the basic science, fundamental discovery that's done in labs, all the way up through the design of clinical trials, that it will make those processes more efficient and more effective.
10:02And maybe if I could, I'll describe sort of each bucket separately. So on the healthcare delivery side, making it more accessible and equitable and safer, a few years ago, our dermatologists worked with some computer scientists. And what they did was to take pictures just with the smartphone of skin lesions, and then annotate those photos with what we knew to be the pathology of the skin lesion. Like, was it a cancer or was it not? And then they trained a neural network from a group of many, many pictures. And then they presented to that neural network, that AI model, new pictures that hadn't been used to train the model of skin lesions and ask, is it cancer or is it not?
10:55And they did that with the AI model. And then they asked a group of, you know, board-certified dermatologists to look at the same pictures. The AI model was as good as the board-certified dermatologist from looking at pictures in discerning whether or not this was a malignant lesion or not. Now, what does that mean? It means that, for example, in a rural area that may not have a dermatologist or even in an urban area, it's not always easy to get an appointment to see a dermatologist. A primary care physician can, with a picture of the skin lesion, get a pretty good indication about, oh, this is something serious and I've got to get this patient in to see a dermatologist.
11:36Or this is probably nothing to worry about. We'll just watch it. So that makes health care more accessible and ultimately, I think, should make it more equitable. I can feel the sort of skin on the back of my neck prickling a little bit because we've all had that experience of toying around with the LLMs out there. And on first glance, you get an amazing result. You're very excited. And you kind of dig a little bit further. And very quickly, you realize like, oh, this might not be as advanced as I originally thought. Errors abound, et cetera. and I'm imagining a situation where the photograph isn't taken quite right or the light isn't exactly correct.
12:16You get a misdiagnosis. So to your point around safety, those are the alarm bells that go off in my mind. But they're the same alarm bells that go off when I think about the prospect of autonomous driving or any of these other technologies that are on the horizon that sort of threaten our illusion of control and safety on some level. Exactly. And all good points. That's why we have to roll out this technology with a lot of oversight, with a lot of insight, and very importantly, with the engagement of the public. This can't be sort of top-down. We have to be very transparent with the public about how AI is being used.
12:56And we have to get feedback on that as it is rolled out. But let me mention another example. Lots of diagnostic imaging studies are done every day across the country. Now, a diagnostic imaging study, whether or not it's a chest X-ray or a CT or an MRI, all that data comes in digitally. We stopped printing X-ray film years ago. Since it comes in digitally, it can readily be used for AI. We know today that across the board of diagnostic imaging, roughly 4 % of the interpretations of those images by humans miss something that's of clinical significance. That doesn't always mean that the patient's going to have an adverse outcome, but something is missed.
13:45Now, if AI, as it's being used today, for example, in chest X-rays, if it can be used to trigger, you know, say to a radiologist, look at the upper lobe of the lung because there appears to be something there. If it can also look back through all the old chest X-rays and say, well, this was there three years ago and this is how it's changed. It's helping. It doesn't supplant the radiologist from making the final decision, but it helps to prevent an error and make the delivery more efficient. To your point around the efficacy of the AI model versus the standard practitioner or specialist's ability to kind of detect based on experience, I would imagine there might be a little pushback from those specialists who are, you know, adamant that they're better at doing this than the model in the same way to extend the autonomous driving metaphor.
14:39Like we think we're better at driving than the robot version, but all the data and statistics suggest otherwise. Is that something that you have to contend with as you go out into the world and talk about these things, that it's the doctors themselves who might be bristling? Definitely. And we've seen this before in healthcare and medicine. For example, when I was in my clinical training after medical school. This was in the early days of angioplasty. And at the time, cardiac surgeons thought, angioplasty is never going to go anywhere. These are all going to fail, and these stents, they're going to get clogged up.
15:18Well, angioplasty and cardiac stents have saved many, many lives, and it continues to get better. And yes, there is still an important role for cardiac surgery. Cardiac surgeons haven't gone away. Likewise, in general surgery, it used to, when we took out a gallbladder, we made a big incision and took out the gallbladder. Now many of those procedures can be done laparoscopically with a tiny incision and much shorter recovery time. What happens over time is that practitioners retrain and medical specialties redefine themselves. I think we'll see this. I don't think radiologists are going away. Not at all.
15:57But there'll be radiologists who use AI in a responsible way and those that don't. And in the end, the ones that do use it will be the ones that are in practice. The immediate and kind of most obvious use case that I see being such a huge benefit is the ability of these models to take massive amounts of data and find patterns or extract meaning from them in a way that humans just aren't capable of doing. Obviously, that leads to the ability to design new precision drugs for specific purposes or to design or refine clinical trials so that they're better suited to the goals of the scientists who are conducting them.
16:42Exactly. And, you know, we talked about the use of AI in radiology, and we talked about that proceeding at a rapid pace because all the data comes in digitally. but I think the impact perhaps is even going to be greater in pathology. So when a tumor is removed, when a growth is removed, it goes to the pathology lab and it gets sectioned. And then a pathologist looks at sometimes even hundreds of slides from that tumor. For rare conditions, a trained pathologist may have only seen a half dozen, a dozen of a particular lesion or abnormality in their career. And what you were just saying, because now we can collect from a variety of different health systems hundreds of these tumors that are rare, we're training a model based on a lot more data than an individual pathologist will be able to see in their lifetime.
17:41So that increases accuracy. It increases precision in knowing what the salient features of a tumor are in ways that no one human being or group of humans can do. What are some of the other benefits? I think you mentioned drug discovery, for example. One of the early applications of machine learning was in the study of protein structure. And now we can predict the structure of a protein just by knowing its sequence very accurately. That's enhancing the drug discovery process. We're already seeing benefits of that. We also have the possibility in the future of designing a drug, if you will, from scratch, just from data about the biology of the condition that's being treated.
18:30And there are companies that are focused on that today. So I do think we will see a revolution in drug discovery. How quickly will that come? That remains to be seen. But the pieces are there to have that sort of an impact. And the better these models get, the more refined and improved their diagnostics become, which translates into earlier detection, right, for these diseases. So the real world kind of ramifications are there's an expedited time period from diagnosis to treatment, but also the early detection piece, which obviously is going to help people resolve these problems before they get too far out of hand.
19:13That's exactly right. It's back to a concept that we've talked about before in Stanford Medicine and elsewhere, a concept we call precision health, which we distinguish from precision medicine. Precision medicine is about getting the right treatment to the right patient for the right disease at the right time. But precision medicine is, if you will, after the fact. It's after someone gets sick. How do we provide the best sick care? And, of course, in the United States, we have the best sick care system in the world because of our specialized care that we offer because of tertiary and quaternary care.
19:51But we haven't focused nearly as much attention on predicting and preventing disease and in detecting it earlier, as you just mentioned. And I think these applications of AI to bettering diagnostics and designing more predictive diagnostic tests. You know, every time we fly on a plane, the engines of that plane are being monitored hundreds of times a minute on the ground. We should be able to do something comparable to that. One of my late colleagues at Stanford, Dr. Sam Gambier, very much had that vision. We should be able to do something comparable to that in diagnostics and develop something along those lines.
20:38Well, we're slowly inching towards that with the advent of consumer technology in the form of like wearables. I've got a Whoop-on. I use InsideTracker. And, you know, we've worked with levels. And I'm going to experiment with SuperSapiens, these CGM companies. Apple Health with the Apple Watch and everything that they're doing. And I know you had this heart study with Apple. I want to hear about that. But I'm curious around the future applications of how the data sets that are extracted from all of these wearables can be used to better predict and better prevent. I'm thinking I had Tim Spector in here who founded Zoe, and he was talking about the massive amount of data that they're able to kind of mine through the Zoe app, which allows them to come up with new therapies, predict diseases, et cetera, and create diagnostic tools as a result of that.
21:35And I think with mass adoption, you're only going to see more and more and more of that. It brings up privacy concerns, of course, but where do you see all of that going? I think wearables have an important place. And you're right, we did work with Apple several years ago on the Apple Heart Study. The question we addressed with the Apple Heart Study was, can the Apple Watch be used to detect the most common heart arrhythmia, atrial fibrillation? And this was a very large study, several hundred thousand people participating in it all virtually. and very rigorously controlled. And yes, the Apple Watch can be used to detect AFib.
22:19That's useful because in many cases, people don't know. Some people have an indication, shortness of breath or other indication when they go into AFib, but in many cases, they don't. We know that people that stay in AFib for any prolonged period of time are at a higher risk of stroke and various other conditions. Now, that is relatively low-hanging fruit in terms of how... That's rudimentary, yeah. That's exactly right. But that opens the door. We do have glucose monitors available today. I think those will become in more common use. There's ongoing work in monitoring blood pressure in a non-invasive, real-time way.
22:59We ought to be able to get a better picture moment to moment on the status of our health and therefore be able to act upon early signs in ways we haven't been able to do in the past. I think the real barrier to true mass adoption is the fact that right now, the marketplace is so diffuse and disperse. And it's like, how many of these things do I have to put on me? I've got this here and that there. It's got to be integrated. And if history tells us anything, Apple's pretty good at that. They sort of take this wait and see approach. And then they suddenly strike when the iron is hot and when the time is right and kind of take over.
23:39I could imagine a scenario like that, but I really do think that that is the future. And I think that these devices, if they've taught me anything, it's given me a sense of agency, like the transparency and understanding what's happening with my body in real time is information that is empowering. It's a little scary. Like, do I really wanna see what's going on with my insulin levels right now? And certainly there are people out there that kind of pushback on consumer CGM adoption. But I think it's just, you know, I think that that can be overcome with education so people understand what it really means when you're looking at this stuff.
24:20And I can't imagine a future where this isn't going to become more and more integrated into our lives. I agree with you entirely. You know, I think the other thing that is going on related to what you're saying is that in the past, in the United States in particular, we've had, as individuals, we've had a passive attitude about our health. We've always assumed, well, if we get sick, we'll go to the doctor and we'll get a medicine and we'll be fine, right? And I have to say that we in healthcare have, in the past, we've, in some cases, we've encouraged that attitude. Really, what we want is for each of us as individuals to first and foremost be responsible for and engaged in our health.
25:09And the role of us as physicians is to partner with our patients. Yes, to have a base of knowledge and skills that help our patients, but fundamentally to enable our patients to take care of themselves. And furnishing information that's actionable to us as individuals is an essential part of being able to take care of ourselves and then helping people understand what that information means. So does that transient spike in your glucose level when you eat a donut, is that going to have a long-term effect if your, say, your hemoglobin A1C is normal? Is that going to have a long-term effect on your health and well-being?
25:48Well, probably not. And by the way, if you just focus on keeping the line straight, you may be... That's going to drive some unhealthy... If you're just eating saturated fat all day because it keeps that, if you gamify it, you can end up in a not so good place. But I think to your point, when you look at what's really killing most people, it's these chronic lifestyle ailments, it's heart disease, it's type two diabetes, obesity, the increasing rates of Alzheimer's and various forms of dementia that seem to be kind of metastasizing right now. And understanding that these illnesses don't happen overnight.
26:29They are growing and taking place over a period of decades. And so if you can detect that something's not right 20 years before the heart attack, you're in a pretty good place to change directions and avert that disaster that is the thing that kills most people. Exactly right. And, of course, that's what maybe cholesterol is. But our health care system isn't really set up for that right now. It's not. It's not. I mean, the example you draw in terms of being able to prevent a heart attack by having your cholesterol level checked and then doing things to lower it, that's a good example of proactive preventative care that has been effective.
27:06And the instance of heart disease has been steadily declining, and our ability to treat it has been increasing. But we need to generalize this across the board, and we all need to be more engaged in healthy lifestyle and evidence-based interventions ourselves in maintaining our health. Talk a little bit about how these technologies are reshaping medical education. What is the experience of the typical med student now versus where you see it going in five years, 10 years as a result of this tech? Well, I'll give you an example. When I was in medical school, not only did we memorize the names of drugs and their mechanisms of action, we had to memorize the dosages of drugs.
27:55That was crazy because the dosage is an arbitrary number. It depends on how the drug is formulated and everything. You can't keep arbitrary numbers in the human brain. But nonetheless, that's what we did and what we were tested on. Well, now, and I talked about electronic prescribing before, we certainly don't memorize the dosage of drugs. We still need to know mechanisms of action and how drugs maybe interact. But in the future, the need for memorization and the need for an active working knowledge base, I think, is going to diminish. What we're going to have the need for is really understanding how to use the data sources that are out there, how to be skeptical when those data sources aren't giving us.
28:42You mentioned the hairs on the back of your neck raised when you hear about how AI is being applied to interpreted images. is we need to make sure that physicians have a lot of skepticism about the information that they're being given from AI, but we also need to train them on how to use it responsibly. So back to your question about medical education, I think we'll continue to see a de-emphasis on memorization because still there is a lot of memorization in medical school. will, in the discovery aspects of medical education, will be training students to use these AI models to ask questions and get informed answers to those questions and then to drive either in patient care or the research they're doing based upon their interaction with AI models.
29:33But I do think medical education is going to be significantly different a decade from now than it has been in the past because of large language models and just the information that they bring to people's fingertips. Has virtual reality found its way into the medical school curriculum? Because there's so many use cases you can imagine of putting those goggles on and participating or observing a surgical procedure or actually going inside the body. Is that happening already or what does that look like? Absolutely. Let me mention two examples. And these are commercially available products. We at Stanford still have our medical students do cadaver dissections.
Read the full transcript
30:19We feel like that's an important part of learning. It's also an important part of developing the culture of respect for the human body. But those dissections are supplemented now by virtual reality and increasingly augmented reality approaches to really understanding the three-dimensional aspects of anatomy. So there are electronic simulations where you can look at any plane you want to in the body. You can insert specific muscles, take away muscles. You can understand the pulling direction of muscles much better than you can from a cadaver dissection, certainly much better than you can from a textbook.
31:00So that's being used today. in a more direct clinical application, our neurosurgeons have a system that, I mean, operating the brain is complex. And every tumor, every structural abnormality is a little bit different. So the surgeon can work with a virtual reality set to actually do the operation virtually, you know, based upon where the tumor is located and be able to see the relationship of the tumor, for example, to blood vessels and things like that before they ever get into the operating room and have a much better understanding, okay, these are the steps I'm going to need to take. This is what I'm going to need to watch out for at this particular point of the operation.
31:44So it's almost like a flight simulator version of a surgical procedure. That's right. Where you're having an almost tactile experience of doing it without the risk. Exactly. Yeah, that's amazing.
32:02After hosting more than 900 episodes of this podcast, I have noticed a pattern. And that pattern is that the highest performers don't buy into the latest trendy hacks. Instead, they obsess on what actually works, which is always the unassuming basics. And there is nothing more basic than hydration. But here's the kicker. Your body can't hold onto water without the right minerals. Without them, water is just like this temporary visitor. But Element has cracked the code on this, which is why I've been using it religiously for years. Zero sugar, no artificial junk, just sodium, potassium, and magnesium in the ratios that actually work.
32:43And look, I'm not exactly crushing ultras right now, healing from this surgery, but in some ways I need it even more. In order to properly recover, I need to treat my body even better than ever so it can heal properly and expeditiously while also maintaining my focus and my energy levels to rock out all of these podcasts, write a book, be a husband and a dad. And I got to say, Element keeps my brain firing in a way that water alone can't. Their new sample pack features their most popular flavors. Citrus salt, raspberry salt, watermelon salt, that's my favorite, and orange salt. Eight stick packs total, perfect for finding your favorite or sharing with a friend.
33:26Get a free eight-count sample pack of Element's most popular drink mix flavors with any purchase at drinklmnt.com slash richroll. Find your favorite Element flavor or share it with a friend. When it comes to health, sleep is a big deal, and there's just so much science out there to back up the role that it plays in every facet of well-being, from heart health to mental health, recovery, cognition, and just being able to show up as your best self. Getting a quality eight hours per night is a personal non-negotiable that I go to great lengths to ensure. It's sort of a commitment not only to myself, but to my career and to those that I love that all begins with what I'm sleeping on.
34:10Now, I've tried many mattresses, but the one that's really won my heart is Birch. And there's many reasons for this, all of which boil down to the simple fact that Birch just does things right. In addition to being incredibly comfortable and cool, helping you regulate temperatures at night, which are essential for quality rest. Birch mattresses are also firm in all the right places, and all their materials are sustainably sourced, including organic fair trade cotton. And also, everything is hypoallergenic and toxin-free, meaning no harmful off-gassing typical of most mattresses. Birch is so confident in their product.
34:47They're offering both a 100-night risk-free trial as well as a 25-year warranty. Plus, they provide free delivery right to your door in a conveniently-sized box-up. And so I want to offer all of my listeners the chance to enjoy a deep and restful night's sleep with a new mattress from Birch. So right now, you can get 27 % off site-wide plus two free EcoRest pillows with mattress purchased. Just go to birchliving.com slash richroll.
35:25I gotta ask, what is the extent of nutrition education in medical school? I've had so many doctors come on this podcast and we had one elective class of nutrition or we only had to do four hours or something like that over three years. Is that changing? What does that look like? I mean, I know Stanford Medical School is very progressive in this regard. I imagine this has been considered, but it seems like, you know, more broadly, you know, it still remains in a bygone era. It is increasing. It needs to increase more. I know you've had Dr. Christopher Gardner as a guest on your podcast, and Christopher is amazing and has been a real champion for introducing nutrition education into our medical curriculum and more broadly.
36:09I think it gets introduced in several contexts, but I'm not for a moment saying that we shouldn't be more focused on it, But it is being introduced now in the standard ways that we teach carbohydrate metabolism, for example. But I think integrating it as well into the clinical curriculum to know how to talk to patients about their nutrition. And, you know, I had a faculty member who a number of years ago did a study looking at obesity to see if offering to a family to replace the cooking utensils in the home with smaller utensils, reasoning that if they're smaller utensils and you cook less, you'll eat less, if that might lead to weight loss.
36:52And lo and behold, yes, it does. So we need to be thinking at all levels of the medical education and care delivery process, how we build in a focus on nutrition, both scientifically and educationally. Healthcare is sick care, to your point. And there's certainly a lot to redress when it comes to our healthcare system. So I wanna put a pin on that for now, but I bring it up because if we wanna truly move towards this new modality of predict, prevent, we have to instill that in the medical education, right? So prediction can be done with all of these new tools better. Prevention often has to do with all these lifestyle interventions, right?
37:39Which includes nutrition, but has other things. And so the common refrain when someone goes to the doctor is that they never make any kind of lifestyle recommendations. It's not really part of what they do. They're time constricted. It's not necessarily their fault. It's a systemic thing. But the more that we can educate our young fledgling doctors around these things, the better chance we're going to have that they are going to carry these principles into their practice. and share that with their patients so that we can be more in a preventative stance when it comes to health care outcomes. Exactly.
38:16And when we talk about prevention, we have to first and foremost look more carefully at behavior because prevention is fundamentally about changing behavior. I'll tell you a story. About a decade ago, shortly after I moved to Stanford, to California, I was getting to know people in our community. I met with a leader in the life sciences venture community. And I said, is there any topic that if someone comes in and tries to pitch you on a company doing this, that you just say, you know, thank you very much, but, you know, appreciate it, but I'm not interested. And he said, yeah, anyone who comes in and tries to pitch me on something that's going to change behavior, I'm not interested.
38:55I was like, oh, dear. Because now, you know, we've seen that change, right? We've seen some real successes in the digital health world. But where I'm going with this is we need to be doing a better job of integrating the study of behavior, the study of lifestyle, study of well-being, much more into the scientific mainstream of research and also into our attitude and our approach to care delivery. because behavior really does underlie a lot of, we mentioned chronic diseases before that are so crippling in our country right now. Every one of those will have a strong behavioral component. When it comes to more progressive modalities around medicine, you hear about functional medicine and integrative medicine, preventive medicine, holistic medicine.
39:48Now we have precision medicine. Like how do we parse all of that? How is what you're talking about with precision medicine different than those other terms? There are many, many similarities, but in particular by focusing on health. Our goals with precision health is to use the same enablers that have been used for years in precision medicine. You know, let me mention an example. We are so much better today treating breast cancer than we were a decade ago. Why? Because not every patient with breast cancer gets the same treatment. The treatment is tailored to the tumor and to the individual. And as a result, we have much better outcomes.
40:32What we should be doing with Precision Health is taking that same knowledge base, knowledge base of genomics, of lifestyle and other things, and applying that in a predictive way to say, well, maybe I need to have these screening tests done every year. Maybe another person needs a completely different set. Now, we already do that to an extent, but we should be doing it to a much greater extent. You know, underpinning a lot of this will be advances in diagnostics, which I think are coming along, but diagnostics are hard. First, you're trying to detect a very small signal, and you need to do it accurately because you don't want to drive a lot of unnecessary testing because of a false positive.
41:19But that work's being done, and I think it is going to lead to more tests that have the same sort of actual value as when you and I have our cholesterol measured, for example. So those are going to be the things that we need to really drive this revolution in prediction and early detection. Right now, medicine is divided up amongst all these various specialties. And it's unclear how much sharing of information or cross-communication there is between all of these fiefdoms. And one real advantage that I can imagine with these AI tools is that they can take massive data sets from genomic testing and, you know, sort of, you know, cross section that with microbiome data and metabolic health data from CGMs, like across the spectrum of all of these different specialties and try to make sense of how they fit together and how that can drive better predictions.
42:20and better early diagnoses. That's right. And that's another strong reason why AI is going to be transformative because bringing together those different sources of data is generally more than the human brain or even any groups of humans can do. We're not capable of doing that. No, exactly. Those data exist and collating them through the benefits of AI and deriving information from the troves of data that exist out there, particularly in electronic health records, I think is a major goal of the application of AI to healthcare delivery. Let's talk a little bit about the cons or the ethical dilemmas that come up as we move towards this near future and the considerations that are underway to kind of address them.
43:11I know you have partnered, you have this organization, it's called Raise Health, right? That's right. So talk a little bit about that and where your head is at. Well, RAISE Health is an acronym for Responsible AI for Safe and Equitable Health. And I think that says it all. How do we deploy AI in an equitable way and in a safe way to improve the health of all of us? So some of the cons, some of the risks that we need to be clearly aware of and mitigate and prevent. First is we have to protect privacy. And there are new dilemmas that are going to arise in privacy that we haven't had to deal with in the past.
43:55For example, with the large language models that exist today, and particularly as those language models start to integrate social media data, you might have a doctor in an emergency room at 3 o 'clock in the morning is seeing a patient who just returned from a trip to South America who has lupus and a few other medical conditions, and this patient has a high fever. And you type in that information into a large language model, even though there's nothing in that that's identifiable. There's no personalized health information in that query. And still, by linking various sources of data, the patient could be identified just from that query.
44:37So we have to think about privacy in a new way. And there are many, many ways of doing it. One is to bring the model into an individual delivery system so that data doesn't get out. You can ask a query and it doesn't get back to a model that's going to be trained based upon the data. Right. That's the whole like, don't worry, we're keeping the AI in the box thing. That is the premise of every dystopic super intelligence movie you've ever seen. True. But that's something privacy has to be front and center. And in President Biden's executive order related to AI that came out just recently, privacy was at the top of the list in terms of what the regulatory agencies have to be focused on protecting.
45:25So that to me is at the top of the list for the downsides or the things we need to protect as we roll out AI. There are others as well. The AI is only going to be as good and as accurate and as reliable as the data used to train it. And if the data used to train AI is biased because it only contains data from white men, for example, then it's going to yield results that conceivably could lead to inequitable recommendations. So being cognizant of the risks of bias and mitigating those risks, of course, mitigating those risks means doing studies that are inclusive, more inclusive of populations that historically have not been included in medical studies or clinical trials.
46:15So bias is another example. I think the other thing we want to protect is the primacy of the relationship between a patient and their healthcare providers, their nurses, their physician assistants, their physicians. If AI supplants that or is somehow viewed as a gatekeeper to getting to a human being, then that's not a good thing. I don't think it will do that. I think it actually will make the interaction between a healthcare provider and the patient more connected. We We probably all had the experience, I certainly have, of going in to see a healthcare provider, and immediately they're typing the note.
46:58And even though, yes, they're listening, right, that's not the same as the conversation you and I are having across the table from each other, looking at each other in the eye. If you can remove the clipboard and make better eye contact and be present with that patient, that's its own healing modality. That's right. And that's within our grasp. So those are some of the things that I think are the downsides that, again, a goal of Raise Health is not to try to say that those are not a problem, but indeed to say they are an issue, raise them to the fore, and responsibly address them. Another goal of Raise Health is to make sure that at every step of the way, we're communicating with and engaging the public.
47:46there was a study done last year by the pew foundation looking at ask the question a general question of a large number of individuals do you trust the application of ai in the delivery of health care not surprisingly overwhelming majority of people said no of course they should say no because we haven't explained to them how it can be used how it is being used today for example, to prevent medication errors and other things, but also to understand what it offers in the future and how we have to work together to prevent the downsides. It's sort of like there's no pilot in the cockpit. You know, I'm imagining a situation in which robotics and automation are in the hospital ICU room and they're calibrating what ends up in the IV drip, for example, or they're administering drugs without any kind of human involvement.
48:43And the potential for that to go haywire is scary enough to, you know, kind of make anyone fear that type of future. For sure. For sure. But I would mention, though, that, again, to your example, the use of robotics in sort up a drug formulation. That's a good example because chemotherapy infusions typically have to be very accurately calculated to someone's weight, their blood count. When we were relying just upon humans to do that without having - More room for error. There definitely was more room for error. And not only room for it, there were more errors. Hmm. So interesting. How are the other big tech players in the private sector considering all of this?
49:42I'm thinking about Walmart and Amazon. Like, Amazon is ripe to sort of get into healthcare in a really big way. Walmart with its, I don't know how many stores they have, but as a vehicle for the greater access that you're talking about, it seems like they could be sort of critical partners in how we revolutionize access. I agree. Walmart, for example, has many of its super stores. They've chosen markets to roll this out in where they can study it and also based upon sort of their assessment of where it will offer benefit, but they have clinics next to the superstore. And they have been very, as is the case in other areas, they've been very transparent about pricing.
50:32How that will generalize to other, given Walmart's closeness to every one in America, in terms of having stores, that remains to be seen. Amazon acquired a primary care delivery system in its recent history. Now, will they generalize that? Amazon, I believe, is getting into also filling prescriptions. Walmart has a very large pharmacy service. So I think the large retailers are definitely looking at ways to make healthcare delivery more efficient and and more accessible by placing it in communities. The larger tech firms, I think, are looking at where they can have impact. We talked about the Apple Watch study before.
51:23We, Stanford, worked with Duke and with a branch of Google or Alphabet called Verily to roll out a project that we call Baseline. This is a study of several hundred individuals where everything about their health has been measured and they're being tracked. There's a wearable that was developed specifically for this study because we want to be able to look at a lot of data coming in and to be able to say, well, there was an early indication, you know, three years ago that we didn't even realize was an indication that maybe was associated with a condition that the person developed. And the only way you can look, you can develop those relationships, discern those relationships is by studying things, what is called longitudinally over the course of several years.
52:14You know, there are studies like that going on. You know, a few things about health care that's a challenge for tech. One is that it's by far the most highly regulated industry in America. and that makes doing broad innovation and application and rollout a challenge. So I think tech firms are being careful of that, but there's no question I think that there will be a bigger role for technology. The wearables we were talking about before in the future, it just has to be done. It's not the same thing as rolling out a new version of a smartphone, for example. Sure, sure. In the same way that we all kind of woke up one day and were informed or realized that everything that we had been doing on social media, chatting with our friends and scrolling and uploading photos and replying and commenting, etc., was not only being tracked, but being mined to such a fine degree and then repurposed and sold to third parties so that we could be advertised to, was a disturbing revelation for most unsuspecting people.
53:30But what you're talking about is the next step of that. Not only are we gonna monitor everything you do on social media, we're gonna monitor your blood work, your heart rate variability, your sleep cycle, your insulin levels, and everything in between. And that data will be used for your own good because we're gonna do good with it. it's not hard to imagine why that could be a difficult sell for a lot of people. For sure. For sure. And right now where, you know, the pop-up comes, do you accept these cookies? And I don't know about you, but I typically just say, I want to get on to whatever I'm doing.
54:09Yes, I accept the cookies. We're going to all have to be much more careful about how we allow or don't allow our health data to be used. I mean, much more careful compared to just clicking, yes, will accept cookies or know we won't. That gets back to this privacy imperative that we have to have. And it does mean that the impact of these sorts of data mining technologies on the actual delivery of care is going to proceed more gradually for good reason than, for example, when I go on Amazon and search for shoes, then all of a sudden when I'm on the New York Times website, have these ads for shoes popping up.
54:53I mean, for sure you can't have that. But now a breach of that trust would be, hey, this guy's not sleeping so well. So suddenly you're getting ads served up on your social media accounts that are advertising supplements to improve your sleep, et cetera, ad infinitum. This is not a world that any of us want to be in. So So safeguarding that data and perhaps even creating a situation where somebody has to opt into that as opposed to opt out. Imagine wearable company X. They're sitting on all this data. We can just sell all this data for a lot of money because there's people out there that can use this to market and pinpoint these people to sell them things.
55:39Exactly. And that has to not occur. I mean, we have to protect it. But, you know, Rich, the history of, and I know you're not suggesting this, none of us is suggesting that we just close the box on applications. That's not happening. That's not happening. That never happens. It would be the first time in human history that we've closed the box. So I think we can all accept that the box is not getting closed. Right. And it's just going to be what it's going to be. And we're going to try to put the guardrails up as best we can. But history also tells us that human hubris always believes that we can better control things that we find out later that we didn't do such a good job with.
56:21So how is this going to be different, Lloyd? And I'm pushing back in sort of in fun jest, but I am curious, and I think these are really important issues. And I know that you're considering them deeply, but these are the things that people are going to want to know if you're expecting them to feel safe and to toggle that opt-in button. Exactly. And one way it's going to be different is because you and I are having this conversation today. I don't think with a lot of technology innovations that have impacted our lives, the conversation is generally post hoc. It's after the fact. oh my goodness, look at the effect that social media has had on, and then fill in the blank, our children.
57:08And I'm not taking a side on that issue. But we're having this conversation today with Raise Health. We're designing the initiative very much with these questions in mind, being more proactive before these larger scale implementations that you're talking about occur. I think the point you raised about opting in, about complete transparency, about how data is being used, and about giving people the option to not have their data used in any way, that has to be a critically important part. Yeah, if you want to engender trust and get buy-in from the public, I think that's absolutely mandatory. Because that trust has been breached in the past, and so it's even harder to earn right now.
57:58And I think for good reason. Absolutely. Yeah. What does the regulatory landscape look like? Like, what is the FDA doing? How are they looking at it? How are people like yourself interfacing with them? Like, what does that communication look like? What are the barriers to this type of technology that regulators are throwing up? And where are the green lights? I think in the case of the FDA, the FDA is really leaning in to learn and understand understand how AI could be used and how they need to be responsibly involved in regulating the application of AI. So there's a branch within the FDA looking at digital diagnostics, for example, or digital healthcare delivery to know how should that be regulated.
58:46The FDA collaborates with or funds institutions like Stanford, for example, with UCSF. We, Stanford, have a Center for Excellence in Regulatory Science and Innovation. It goes by the acronym CIRCY. So we have faculty at both institutions doing the science that informs regulation. The FDA funds this. They receive the reports. They're very much involved in the activities of the center, but the FDA is partnering with or gaining information from those that are doing the primary AI and healthcare work to know how they need to be involved in regulation. Likewise, the Department of Health and Human Services, through the Office of National Coordinator of Health Information Technology, is very interested in how AI is and can be deployed in medical records in the future.
59:39So I think the governmental agencies are taking a responsible approach of wanting to understand the landscape and know how they can and should be developing the regulations that absolutely will be needed. But I'm encouraged. I've gotten to know and learn from Some very, very dedicated public servants at HHS, at the FDA, both through their own work and the work that they are engaged with us and other institutions in are gaining the knowledge needed to do responsible regulation. And regulation has to be a part of this. Sure. It's not hard to imagine the many ways in which these technologies are going to kind of upend health care.
1:00:28But at the same time, our healthcare system is pretty recalcitrant to change. It's Byzantine. It's complicated. It's confusing. It's expensive. It's broken in so many ways. And many a person has tried to untie this knot and sort of slinked away unsuccessful in doing this. How can we change this system and make it better? irrespective of AI or maybe in partnership with AI, like we need a better system and incremental changes don't seem to be the way forward because it's so systemic. So how are you thinking about that big problem? It is a big problem. And, you know, we could spend another series of podcasts with a lot of other people talking about how we got to where we are right now in the U.
1:01:19health care delivery system. We do have, and we talked about this before, a great sick care system in terms of providing ultra-specialized care for severe acute illnesses. But we don't have a great system for preventing disease and also for allowing a broad-based access to the care that people need. Look, what I think about as a leader of an academic health system is what we need to think about is where we can have beneficial effects, where we can do things that lead to benefit that are actionable. And that is, by definition, incremental. For example, if deploying AI in the interpretation of chest x-rays eliminates or dramatically reduces the 4 % of missed significant abnormalities, then we've improved care delivery.
1:02:13And if we show how it can be implemented into workflows, in ways that radiologists embrace it and not push it away, and we talk about that, and others do it as well, then we've led by example. So a lot of what we try to do is think about how can we responsibly innovate, study, rigorously study an innovation that we've introduced into the delivery system, and then talk about what works in ways that lead to others adopting it. I think that's a primary responsibility for us as an academic health system. At the broader health care delivery system level, if you look at Medicare, for example, moving to Medicare Advantage plans that better align incentives for keeping people healthy rather than after-the-fact care when people get sick.
1:03:05If there are incentives for providing in-home care rather than having people go to the emergency department every time they have an issue or problem. I mean, those are things that I think the Medicare system is doing to make Medicare first better for patients and more efficient. I don't think there's going to be a massive top-down overhaul of the U.S. health care delivery system in a way that's implementable, but through a series of these interventions, I think we can and will have a better delivery system. Those are measures that are oriented around acute symptomology, but it's still a long way to go to get into the predict and prevent.
1:03:49But I can imagine with these tools, the diagnostic tools, the wearables, and all of these things, that there can be a more seamless transmission of data to your primary care physician, and they are kind of in constant communication with all of their patients and are alerted if something is awry, again, there's privacy concerns with that. But to the extent that these tools can allow us to communicate more seamlessly with our caregivers, I can imagine that would be quite disruptive in a good way. Absolutely. And can allow us to get information about in-home monitoring, for example, and real-time information about when a person with chronic diseases, for example, has some early signs that their health is about to rapidly decline.
1:04:45And to be able to intervene before it gets so severe that they need to come into the hospital. So we do that today with visiting nurses, but increasingly we should be able to do it with electronic monitoring. Again, privacy is a big concern. But those are the types of things. The other thing to keep in mind, Rich, about U.S. health care is that 70 % or roughly of the determinants of disease in our country, and it isn't just restricted to the U.S., 70 % are socially and environmentally mediated determinants. So the social environmental determinants, social behavioral environmental determinants of health, things like access to the right food supply, behavioral health issues play a big role.
1:05:31And historically, we haven't done a great job in the U.S. of addressing those social behavioral environmental concerns. One of the things that we're trying to do as an academic medical center and school of medicine is through our Department of Health Policy is to, again, do what we do well, which is to do rigorous research and then to disseminate the information from that research in ways that it can help drive policy changes and help informed interventions. I mentioned before about replacing cooking utensils in homes with smaller utensils, and that being a positive driver of weight loss. So things like that, they're incremental, but they do have impact.
1:06:18Right. The idea that your zip code determines your health outcomes in too many ways than it should, that's not going to eradicate the fact that somebody lives in a food desert or just doesn't have access to healthy foods or isn't in an environment that's conducive to moving their body in a healthy way, et cetera. But those smaller interventions, they're still meaningful, but the problem is so much larger than that. And it transcends healthcare. It's really about our urban landscape, et cetera. Precisely. And economic disparity.
1:07:00I own a bunch of spectacles, and I made the grave error the other day of donning a normal non-Roka pair on my indoor trainer when I was riding my bike indoors. And I got to tell you, it was a disaster. Every three to five seconds, I had to take my hands off the handlebars and push my glasses back up my nose until I got so frustrated I just tossed them aside. This is the dilemma of every active but optically impaired person I know. And as someone who has relied upon eyewear every single day since I was five years old, it is also the source of endless aggravation. Thankfully, now eradicated thanks to Broca, the stylish performance eyewear company founded by two former Stanford swimming teammates of mine who have gifted everyone like me and, quite frankly, the world with their fashionable line of super lightweight prescription glasses and sunglasses with patented no-slip nose and temple pads that are just impervious to sweat.
1:08:04And no matter what you do, remain locked on your mug no matter how intense your workout. Without the dork factor, these things go everywhere with me from the trail to the dinner party. Put them on, feel the difference, and wear without limits. Unlock 20 % off your order with the code RICHROLL at roka.com. That's R-O-K-A dot com.
1:08:35What is the near-term future and the far-term future? I've had futurists in here. I had Peter Diamandis in here. He's painting some crazy picture of what it's gonna look like. You seem like a much more grounded person. But what does five years look like if these advances continue to move forward? What does 10 years look like? Are you willing to get into the prediction business for five minutes and share a little bit about that? Or are you gonna be too circumspect? No, I can get into the prediction business, but I have to say my crystal ball is pretty cloudy. And also I am an optimist, But I've also seen enough reasons for optimism, and I think that's important, particularly in the environment today where it's been challenging for many people to be optimists.
1:09:28So what do I predict, say, in the next five years? I do think that the field of early detection diagnostics, so being able to have screening tests that provide an early signal that a cancer, in the tumors that historically have been diagnosed much later than they should be, pancreatic cancer, ovarian cancer, I think there's good reason to be optimistic that we will have diagnostic tests. There are already some that are available. they will get better and better and there will be more and more. And therefore, we'll be able to say to a person, you know, based upon your genetic risk profile, you know, you should have this screening panel looking for cell-free DNA in a tumor from a blood test.
1:10:19You should have this done every year. And those signals will then help, you know, to detect those tumors much earlier. That's within our grasp, and I think that will be rolled out. I also think our ability to do in-home monitoring of conditions will improve and that we'll have fewer hospitalizations that could have been prevented if we had seen the decline in various parameters and intervened earlier. I think that's going on and will have increasing impact in the years to come. You know, coming out of COVID, and COVID was certainly a defining event for everyone as individuals and as a society.
1:11:01But it was particularly a defining and horrific event for healthcare providers because we were on the front line throughout COVID. And I gained so much inspiration from the colleagues I worked with every day as we at Stanford and in our region navigated the challenges of COVID. But we also had to be aware that we have a health care workforce today that in so many ways is burned out. And I think now that we still have a lot of COVID around, fortunately, not many people requiring hospitalization. But I think rejuvenating the healthcare workforce, it is a resilient group of people for sure, but we've got work to do on rejuvenating that workforce.
1:11:52And I think that is something that we will accomplish over the course of the next three to five years. We've always attracted people to health care and medicine who have extraordinary dedication to the mission, but they don't have an infinite reserve of resilience. And rebuilding that now is particularly important. How do those tools aid with burnout? One thing is how do we get people away from the computer terminal? How do we reduce the amount of time that a healthcare provider has to spend doing documentation? How do we help a physician with the inbox? It's great. Patients should be able to ask questions of their physicians directly and in a secure way.
1:12:40But if that's adding on two hours of work after eight hours in the clinic in addition to documentation, that contributes to burnout. Those are all things that technology is today already beginning to have impact. And I think in the futurist sense, it's going to have even greater impact over the next five years. Getting health care providers, physicians back to what they went into the profession to begin with, and that is to be able to interact directly with people during some of the most challenging times in their lives. How far away are we from a future in which there's a pod in your house that you slip into every day or once a week?
1:13:22It scans you. It detects everything that's slightly off in your body, sends it to your doctor or prescribes a protocol to address it. Hey, there's a little cluster of cancer cells here. Let's get that taken care of right away. that kind of thing that you see in sci-fi movies. Yeah. I don't think that's five years away or maybe not 10 years away. I didn't say five. Is there a future in which that is a thing? Oh, sure. I mean, look, who would have thought 25 years ago that the smartphones you and I are using are doing what they're doing today? I mean, a few futurists would have predicted that. A few people did.
1:14:08and created companies that have been remarkably successful. But most people had enormous skepticism about it. To the example you mentioned, already today there are centers, they're not covered by and large by insurance, but where you can go in and get a whole body MRI. Yeah, like a DEXA scan. Yeah, exactly. And a DEXA scan for looking at bone, but a whole body MRI to detect, you know, whatever. Now, it turns out that those also sometimes detect things that aren't really a problem. If you go in and do that, they're going to find something. That's right. And then what do you do about it? Yeah. So there's a ways to go.
1:14:45But as you and I, you said before, our history of putting things in a box and closing the box and saying we're never going to open it, that never works with technology. The general theme here is that there will be some revolutionary changes in diagnostics. diagnostics. There will also be, if we're looking at applications of AI, there will also be revolutions in drug discovery that are going to help to have better therapeutics that really are tailored to specific conditions in individuals. And that's going to improve health and well-being. Where are we in terms of growing organs? I was at a conference, Sanjay Gupta's conference, and I can't remember the doctor's name.
1:15:32I think she was growing like heart tissue or I don't remember. Maybe you probably know who this person is, but it was pretty remarkable what she was sharing and the future that she was painting. And I think that if Uma Valeti can create hamburgers and steaks and chicken fillets out of brewing these cells, that harvesting or sort of fermenting and growing these organs doesn't seem like that far distant from that. I agree with you not only growing them, but as one of our faculty members at Stanford is doing, 3D printing them. Yeah, that's what I was thinking. With living tissue.
1:16:21It's in the lab today. As to when it gets to patients, it's a bit hard to predict. and we do a lot of things in the lab that then getting them into patients requires many more steps than we thought it would. But it definitely is going to happen. And so, for example, in congenital heart disease, that is children that are born with heart abnormalities, we're going to have a lot more options for treating that than we've had in the past. In the past, There are ways that you could sometimes bypass the problem and some very innovative cardiac surgery techniques. Heart transplantation has become more common.
1:17:07But if we can actually build chambers of the heart, 3D print them, and then put them on the heart and have them function, then we've introduced a whole new way to correct congenital abnormalities of the heart. That conceptually is here today. Just there are a lot of steps between what's going on in the lab and getting it to patients. Well, it feels like a really exciting time if you're a young person to go into the biomedicine field to be a med student right now because so many things are changing so rapidly. Like it feels very different than even a few years ago. I completely agree. And we have the privilege every day of working with some of those young people that bring so much inspiration and energy and vision to all of us.
1:17:58There's never been a better time to be in the life sciences than today. Why? Because there has been a convergence of so many different areas of science and technology now being applied to biomedicine. We talked about 3D printing, which began, obviously, in terms of printing objects. Now we're printing cells. That's going to be a whole field. Right, right. are the application of AI to the study of protein structure and being able to predict therapeutics based upon the knowledge of protein structure. There are just so many things that other fields of science and engineering and technology that maybe as recently as five years ago had been considered as completely different from life sciences.
1:18:41Now those fields are very much a part of and are being applied in the life sciences. That's what makes this such an exciting time. What are your daily health practices as somebody who knows a lot and is on the forefront of learning about what's new and what really moves the needle in terms of trying to maintain your health optimally? What are the things that you do every day? Or maybe what are some of the changes that you've made in recent years? Well, having lived in California now a little over a decade, it's easy. A little different than Baltimore. A little different than Baltimore. Baltimore is a fantastic place.
1:19:22But we get fresh fruits and vegetables here, and that's a large part of my diet is consuming those. I'm not a vegetarian. I do eat meat products, but I do it probably fairly sparingly. I go to the gym. I try to get to the gym three mornings a week. I try to get some cardio exercise every day. I generally, I just started several years ago not eating breakfast. I actually found when I started, I tell you when I started doing it, I started doing it during COVID when everything was so incredibly busy. We would typically start meetings at 7 a.m., sometimes earlier during COVID. So it just wasn't time to eat breakfast.
1:20:05I found myself getting to lunch and, wow, you know, I actually feel pretty good. And so the intermittent fasting has become a part of my routine. I'm not recommending it to others. You just simply ask what I'm doing. And so those are some of the things. Try to eat sensibly and responsibly and get exercise. And you're a cello player. I am. Do you still play? I do. I do. That was a silver lining of COVID for me because I didn't get on an airplane for 18 months. And it was, you know, the evenings, there were constant Zooms, but I could practice again. And I also discovered that Zoom works pretty well for music lessons.
1:20:51So I tracked down my teacher from the East Coast and said, are you doing Zoom lessons? He said, of course. And so that became a weekly routine. And then I started playing with some other groups and some very talented young people. And now, of course, we're back to the real world, and it's become more of a challenge to practice, but it has been good. I saw a video of you playing the cello with Condoleezza Rice playing the piano. Condoleezza Rice is an amazing person, amazing pianist. That was wild. One question I always ask every doctor that I have on the show is, if you woke up in a parallel universe and discovered that you were the Surgeon General of the United States, what would be your priority?
1:21:35What would be your mission statement? What would you focus on? Yeah, and you've had the Surgeon General. I mean, I had him, and then I said, now I actually have him. So I can't ask him that question anyway. I think what I would focus on are the things that help us, each of us as individuals, engage with our health and our health care in transformative ways. So making information about our health readily available to everyone, not just a particular socioeconomic group or particular educational level, but making health information available and accessible. I would also focus on the responsible regulation of things that we know harm health.
1:22:25And already there's being a lot done on that, but a lot more could be done. I would also focus on making sure that we had a healthcare delivery system and a discovery pipeline that focused attention on diseases and disorders that were most prevalent in the society. What would that look like? I'm not sure I totally understand what you're saying. Well, for example, new ways to treat high blood pressure in addition to our existing therapies. new ways to treat, and we're already seeing this, for example, high blood glucose and obesity. GLP-1 agonists are doing that very effectively. It took a long time to get to those.
1:23:12Some of that was a scientific problem, just working out the science to develop an effective GLP-1 agonist. But others, I think another reason was it just wasn't at the top of the list in terms of where where the emphasis was on discovery. So those are some of the things that I'd wanna focus on. We all know that if we're having some kind of symptom, the last thing we should do is go online and look at what people are saying on WebMD or just be an armchair physician and try to diagnose ourselves. Of course, lots of people do that. There's a temptation to do that. But now we have these LLMs right at our fingertips.
1:23:59So when we're experiencing something, we're gonna wanna type it in and see what these LLMs are gonna tell us about, what we might have and what we might want to do about it. What is your sense of how reliable they are currently in terms of engaging in that kind of behavior? I know you've spent a lot of time playing around with these things. Is that a wise thing to do? Is that something you should avoid doing in the current state? I don't think you should avoid doing it. I think you ought to have a healthy degree of skepticism on what you see. But back to our previous topic of don't put things in a box and shut the lid.
1:24:42First encounter, I mean, I started playing around with large language models when ChatGPT came out in November of 22 or around there. But the first indication that I had that this was really going to be transformative came from, I was asked to give a talk reviewing my research over the summer at a course. And it gave me an opportunity to update things. And I just went online, and I'm probably best known in my field for the discovery of an inner ear disorder. And I just went to, this was chat GPT, even before GPT-4 or Claude or other large language models. I'm gonna ask it about the thing I know the most about.
1:25:22Correct, yeah. And just see, and it was really good. I mean, even some of the subtleties it got, and I recognize some of the language in what it was writing, but the description of the syndrome was accurate. There were, at least in the response I got, there were no hallucinations or glaring abnormalities. Now, when I started pushing it with more and more detailed questions, then, yeah, it falls apart. It falls apart. But I wouldn't shy away from it. I think back to your original question, I think the so-called Dr. Google has been a good thing. When I moved at Johns Hopkins from being a department chair and a physician surgeon scientist to being provost to the university, needless to say, my patient care activities and my research got curtailed.
1:26:13But when I was a very active physician, surgeon, scientist, people would oftentimes come in having found me because of a search they did and a diagnosis they had made, in many cases correctly, of an inner ear disorder that I discovered and described. So I think people should be using them, but they should have a high degree of skepticism. But the more knowledge someone has about their health, about their well-being, the better it's going to be. What is the message that you most want the average consumer who's watching or listening this to kind of understand in terms of the intersection between technology, medicine, and the future that is upon us?
1:27:01I think the message I would want people to know is that there's a stronger potential for good than for bad. But we have to keep our eyes open and be very much focused on the bad that could result from the misapplication of the technology. And consumers have to be actively engaged and involved in knowing how information about their health is being used. And healthcare delivery systems have the obligation to furnish that information. And as you were saying before, to give people the option to opt in if their data is going to in any way leave the ecosystem, that has to be done with their full knowledge and understanding of how it's going to be used.
1:27:45And what is your message to the young, aspiring med student? There's never been a better time. And I think our medical students today very much have that attitude. You know, we continue, not just at Stanford, but across the board, to see record numbers of young people apply to medical school, apply to Ph.D. programs in the biosciences to do the types of discovery-based research that are going to drive the innovations we've been talking about today. Record numbers of highly qualified people are interested in these fields. And I think it's because of the opportunities we've been talking about. Part of me feels like you're in the wrong job.
1:28:23You could be this communicator at large around these ideas and be at the intersection between the private sector and the government or the kind of consumer AI watchdogs to guardrail and definitely guide this technology forward. I guess that's what you're doing, but you have a lot of other responsibilities and obligations in your current role. Well, as I said before, it's never boring. Look, I derive so much energy from the people that I have the privilege of working with every day, and communication is a part of it. In fact, communication is such a critically important part of any leadership role today.
1:29:10I don't think it's ever been more important than it is today, communication, because there's so many opportunities for messages to get misconstrued or for things to be not connected in the way that they should be. We have a leadership academy for people in faculty in the School of Medicine who are thinking about, these are generally mid-career faculty who have already proven themselves as accomplished scientists, physicians, other experts, but who think they may want to move into leadership roles. And a lot of that leadership academy is focused on how to be, first, a good listener, and second, a good communicator, and how to really engage meaningfully with others.
1:29:54I mentioned to you a conversation I had about a decade ago with a venture capitalist who said that he didn't like to focus on anything that purported to change behavior. And another conversation I had with another venture capitalist, I asked for what do you look for when you're evaluating an entrepreneur? Because you're deciding on investing in an idea, but you're also deciding on investing oftentimes in one person or a very small group of people. and what advice do you give to them when you take them under your wing and fund their company? And what this person said was, you know, don't assume intentions.
1:30:32You know, focus on situations, realities, but so much time and energy, psychological energy, time is devoted because we think, well, why did this person say that? Or maybe they were thinking this. If you have a question, ask the question. If you have a concern, express the concern. But we need more transparency in our communication. I think that was the essential message. And it's something that I've tried to do in being available, but also reaching out when I have a question or I have a concern, expressing it, giving and introducing a dialogue that can lead to a meaningful solution. Well, you're a very effective communicator.
1:31:20And I think being adept at science and medicine doesn't necessarily mean that you're effective at communicating these things that you know so much about. Those are two very different skill sets. and most people in the sciences or most people in general aren't schooled or educated in how to translate their expertise in a way that is meaningful for other people, which is why I think it's so important that people in the sciences who are kind of at the front lines or the vanguard of new things be better skilled at how to communicate those ideas. I agree with you. Communication is critically important in everything we do.
1:32:05And the other message that I think we can all learn from is I believe we can all learn to be better communicators. And it's not like you reach a plateau, right? But it's like learning anything, whether it's learning to ride a bike or learning biochemistry. You have to be intentional about it. You have to focus energy on it. You have to focus your intellect on understanding how to communicate and also really looking critically at when you're not communicating well. And I depend upon others to give me feedback on if I haven't explained something. And usually it's because we're all busy. It's an error of omission rather than commission.
1:32:51In other words, that we just haven't reached out or there was an opportunity to have engaged people in a different way at a different time that would have led to more effective, transparent communication. The other thing about that is it's helpful for all of us as leaders to be vulnerable, to enter into interactions in a way that we want to learn from others. We're still evolving. I'm still evolving as a leader, as a person. And join me in this journey. That resonates with people. I do believe at the core people are inherently good. and people respond to requests for meaningful engagement and people respond to leaders who come across first and foremost as caring individuals.
1:33:47Well, if you want to engender trust, that's the primary thing. You have to be willing to be vulnerable. You have to say when you don't know the answer. You have to admit when you got it wrong. And I think those lessons are ones that need to be learned on a health care public policy front as well. You mentioned COVID. There were missteps and mistakes that were made with that that I think denigrated the level of public trust in the sciences and in our health care system and how we kind of advocate what people should and shouldn't do. And we need to rebuild that trust. That's exactly right. You mentioned before, when we don't know the answer to something, we need to say that we don't know.
1:34:33I mean, remember early on in COVID when we all washed our fruits and vegetables coming home? I will never forget that. So that didn't prevent the transmission of COVID. We didn't know that at the time. But we do have to be better at communicating uncertainty and at building trust from the public that medical knowledge, any knowledge evolves as we get more evidence. And particularly when we're dealing with something new. Yeah, it's a moving target, things are changing, people are doing the best they can under the high pressure circumstances of the day. But I think being able to kind of say, well, we got that one wrong, we should have done this, now we know better.
1:35:17But doubling down on we were right, is not the way forward. No, I agree with you. So hopefully that was, I mean, And it's like, did we, like for the next pandemic, are we ready for that? Like, it's kind of scary what might happen. It is scary. Did we learn the lessons we needed to learn to be better prepared the next time? Because there will be a next time. There will be a next time. And I'm not sure. There are people on both sides of that debate. Of course. But, and I think the other thing about it, the did we learn is maybe we could rephrase and say, are we learning? because I think that process is still ongoing.
1:35:57And also I think some of the working through of the burnout and just the toll that COVID has taken on all of us, that's still ongoing and we still will have the, we need the benefit of a bit of an interval. The danger is that once COVID really leaves our minds and we won't focus on making the changes we need to make, We have to avoid allowing that to happen. I've heard, for example, that during COVID, we had an issue with supply chain in personal protective equipment. Are we rebuilding the stockpiles in the way that we need to build them? Before COVID, healthcare delivery systems used just-in-time ordering.
1:36:49You didn't like to keep big warehouses. It was inefficient. Things would go past their expiration date. So you would get things in just in time. Well, guess what? That works if you can predict your demand. But when you have an unpredictable perturbation and you run out of supplies, so are we thinking about building up the supplies that we need and doing it in an enduring way? Those are important questions. Yeah. Yeah, hopefully there's smart people who are working on that and thinking about that while we work hard to rebuild trust. Well, look, it was an honor and a pleasure to have you here today.
1:37:30It was an honor for me, thank you. I have tremendous respect for the role that you, the responsibilities that you hold and the way that you advocate publicly around the ideas that you care about. And although I said, you know, maybe you would be better in a different job, I'm very glad that you're in the job that you're in. Thank you, Rich. And yeah, if there's anything I can do to be of service to you, please let me know. It's been an honor. This was a delight. Thank you for the conversation. I appreciate it. Thanks. Peace. Peace. Plants.
1:38:06That's it for today. Thank you for listening. I truly hope you enjoyed the conversation. To learn more about today's guest, including links and resources related to everything discussed today, visit the episode page at richroll.com, where you can find the entire podcast archive, as well as podcast merch, my books, Finding Ultra, Voicing Change in the Plant Power Way, as well as the Plant Power Meal Planner at meals.richroll.com. If you'd like to support the podcast, the easiest and most impactful thing you can do is to subscribe to the show on Apple Podcasts, on Spotify, and on YouTube, and leave a review and or comment.
1:38:51Supporting the sponsors who support the show is also important and appreciated. And sharing the show or your favorite episode with friends or on social media is, of course, awesome and very helpful. And finally, for podcast updates, special offers on books, the meal planner, and other subjects, please subscribe to our newsletter, which you can find on the footer of any page at richroll.com. Today's show was produced and engineered by Jason Camiolo, with additional audio engineering by Cale Curtis. The video edition of the podcast was created by Blake Curtis, with assistance by our creative director, Dan Drake.
1:39:29Portraits by Davey Greenberg, graphic and social media assets courtesy of Daniel Solis. Thank you, Georgia Whaley, for copywriting and website management. And of course, our theme music was created by Tyler Pyatt, Trapper Pyatt, and Harry Mathis. Appreciate the love, love the support. See you back here soon. Peace. Plants.
1:40:11Thank you.
From the publisher
This week, I am joined by Dr. Lloyd Minor, the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dean Minor talks about the transformative potential of AI in healthcare delivery, research, and diagnostics. We discuss its nuanced pros and cons, including impacts on accessibility, safety, and efficiency. Dean Minor examines AI's benefits in drug discovery, Precision Health, and early disease detection. He elaborates on wearables and the shift towards a proactive approach, integrating tools like virtual reality into medical education and emphasizing nutrition in training. Addressing ethical considerations and industry influence, we delve into the regulatory framework driving transformative changes. We also explore groundbreaking diagnostics, envisioning a future revolutionized by growing and 3D printing organs, and much more.
Enjoy!
Show notes + MORE
Watch on YouTube
Newsletter Sign-Up
Today’s Sponsors:
Brain.fm: Focus music for productivity—listeners can get 30 days FREE 👉brain.fm/richroll
Waking Up: Get a FREE month of mindfulness resources plus $30 OFF 👉wakingup.com/RICHROLL
AG1: Get a FREE 1-year supply of Vitamin D3+K2 AND 5 free AG1 Travel Packs 👉drinkAG1.com/richroll
Faherty: 20% OFF your first order when you use the promo code RR20 👉FahertyBrand.com/RICHROLL
Roka: Unlock 20% OFF your order with code RICHROLL 👉ROKA.com/RICHROLL
Go Brewing: Use code Rich Roll for 15% OFF my favorite non-alcoholic brews 👉gobrewing.com/discount/richroll




